Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
78.4M
-
Number of holders
-
99
-
Total 13F shares, excl. options
-
36.4M
-
Shares change
-
+640K
-
Total reported value, excl. options
-
$618M
-
Value change
-
-$10.8M
-
Number of buys
-
56
-
Number of sells
-
-32
-
Price
-
$16.98
Significant Holders of Replimune Group, Inc. - COMMON STOCK (REPL) as of Q1 2022
111 filings reported holding REPL - Replimune Group, Inc. - COMMON STOCK as of Q1 2022.
Replimune Group, Inc. - COMMON STOCK (REPL) has 99 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36.4M shares
of 78.4M outstanding shares and own 46.39% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (6.02M shares), Omega Fund Management, LLC (4.67M shares), Redmile Group, LLC (3.69M shares), Atlas Venture Life Science Advisors, LLC (3.21M shares), STATE STREET CORP (1.71M shares), VANGUARD GROUP INC (1.63M shares), BAKER BROS. ADVISORS LP (1.61M shares), EMERALD ADVISERS, LLC (1.13M shares), FMR LLC (1.08M shares), and EMERALD MUTUAL FUND ADVISERS TRUST (986K shares).
This table shows the top 99 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.